Preface
Newer approaches to the study of monoamine oxidase inhibition
K.F. Tipton, D. Balsa and M. Unzeta
cDNA cloning of human liver MAO-A and MAO-B
J.C. Shih
New aspects of the substrate specificities, kinetic mechanisms and inhibition of monoamine oxidase
T.P. Singer and R.R. Ramsay
Isoquinolines and quinolines as inhibitors and substrates of monoamine oxidase
M. Naoi, H. Parvez and T. Nagatsu
Tribulin and isatin: an update
V. Glover and M. Sandler
Endogenous MAO inhibitors in brain
T. Egashira
Hepatotoxicity of monoamine oxidase inhibitors in isolated and primary cultured hepatocytes of rat
M. Tsuji, K. Kodama, M. Okazaki, H. Yasuhara and K. Oguchi
MAO in hypertension
M. Minami, H. Matsuda, N. Hamaue, Y. Monma, N. Yamazaki, H. Togashi, M. Yoshioka, H. Saito and H. Parvez
A role for monoamine oxidase in the development of Parkinson's disease?
H. Kinemuchi, Y. Arai and C.J. Fowler
Localization and activity of multiple forms of MAO in human eye
E. Uchida, K. Oguchi, Y. Kiuchi and H. Yasuhara
Human brain MAO
M. Gerlach and P. Riederer
Reversible monoamine oxidase inhibitors: from laboratory to clinic
A.M. Cesura, J.G. Richards, G.B. Picotti, R. Kettler, R. Imhof and M. Da Prada
Clinical pharmacology of MAO inhibitors
P.R. Bieck, K.-H. Antonin and R. Schulz
Some clinical implication of MAO-B inhibition
J. Knoll
Monoamine oxidase in neuro-psychiatric disorders
L. Oreland
